BOSTON, May 28, 2025 -- Aktis Oncology, Inc., an oncology company focused on unlocking the breakthrough potential of targeted radiopharmaceuticals for patient populations not addressed by existing platform technologies, today announced...
Art Pappas to participate on panel, "Investing in Neurotech" at Neurotech Investing and Partnering Conference in Boston, MA
News | 05. 19. 2010
